comparemela.com

Amy Schacterle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Postpartum depression pill shows promising results, study finds

Zuranolone is not yet approved by the Food and Drug Administration, but the agency is expected to make a decision in early August.

United statesAmy schacterleDrug administrationAmerican journalSage therapeuticsPostpartum depressionSage therapeuticsClinical trial dataDepressive symptomsAmerican journal of psychiatryWithdrawal symptomsStudy authors

Postpartum depression pill zuranolone yields significant improvements, clinical trial data shows

Zuranolone is not yet approved by the Food and Drug Administration, but the agency is expected to make a decision in early August.

United statesAmy schacterleDrug administrationAmerican journalSage therapeutics

vimarsana © 2020. All Rights Reserved.